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ABSTRACT
Objective: Previous literature has suggested that laws and regulations may impact the use of
palliative sedation. Our present study compares the attitudes of French-speaking physicians
practicing in the Quebec and Swiss environments, where different laws are in place regarding
physician-assisted suicide.
Method: Data were drawn from two prior studies, one by Blondeau and colleagues and
another by Beauverd and coworkers, employing the same two-by-two experimental design with
length of prognosis and type of suffering as independent variables. Both the effect of these
variables and the effect of their interaction on Swiss and Quebec physicians’ attitudes toward
sedation were compared. The written comments of respondents were submitted to a qualitative
content analysis and summarized in a comparative perspective.
Results: The analysis of variance showed that only the type of suffering had an effect on
physicians’ attitudes toward sedation. The results of the Wilcoxon test indicated that the attitudes
of physicians from Quebec and Switzerland tended to be different for two vignettes: long-term
prognosis with existential suffering ( p ¼ 0.0577) and short-term prognosis with physical
suffering ( p ¼ 0.0914). In both cases, the Swiss physicians were less prone to palliative sedation.
Significance of results: The attitudes of physicians from Quebec and Switzerland toward
palliative sedation, particularly regarding prognosis and type of suffering, seem similar. However,
the results suggest that physicians from Quebec could be slightly more open to palliative sedation,
even though most were not in favor of this practice as an answer to end-of-life existential suffering.
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INTRODUCTION
Sedation at the End of Life
The use of sedation is increasingly accepted as an in-
tervention of last resort to relieve intractable phys-
ical symptoms at the end of life. There is also a
growing tendency, still controversial, to employ this
intervention as a response to severe existential
and/or psychological suffering (Claessens et al.,
2008; Bruce & Boston, 2011; Cherny, 2006; National
Ethics Committee and Veterans Health Administra-
tion, 2006; Morita et al., 2002; Moynier-Vantieghem
& Beauverd, 2008; Chater et al., 1998; Seale, 2010).
Palliative sedation is defined here as a practice
primarily intended to relieve refractory symptoms,
that is, symptoms that cannot be suitably con-
trolled through appropriate efforts with a tolerable
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intervention without compromising consciousness
(Cherny & Portenoy, 1994) in an imminently dying
patient, as opposed to practices intended to deliber-
ately shorten or end a patient’s life (Bruce & Boston,
2011; Rys et al., 2012). The nonstandardized termi-
nology used in the literature (Claessens et al., 2008;
Beel et al., 2002) and the inconsistency in the defi-
nition of sedation (Claessens et al., 2008; Chater
et al., 1998; Beel et al., 2002; Braun et al., 2003; Coo-
ney, 2005) have been widely documented. Variability
in the use of sedation across countries is also reported
(Claessens et al., 2008; Miccinesi et al., 2006; Fain-
singer et al., 2000b; Anquinet et al., 2012), due likely
to cultural differences (Fainsinger et al., 2000b; An-
quinet et al., 2012; Fainsinger et al., 2000a), ethni-
city (Curlin et al., 2008), or religious proscriptions
(Seale, 2010; Curlin et al., 2008). The utilization of
sedation also varies among clinicians (Cowan &
Walsh, 2001), which may be explained in part by
the great difficulty involved in deciding on the use
of sedation (Morita et al., 2002; Chater et al., 1998;
Gonza´lez Baro´n et al., 2005) and the poor under-
standing of sedation as a means of controlling end-
of-life suffering (Seymour et al., 2007). Fear of
hastening a patient’s death and its legal implications
may also deter its use (Rousseau, 2006). Previous
studies have shown that some clinicians associate
palliative sedation with a risk of shortening a
patient’s life (Morita et al., 2002), while others who
had administered sedation more or less had the in-
tention of hastening death (Seale, 2010; Rietjens
et al., 2006; Douglas et al., 2008). However, this con-
trasts with the findings of other studies refuting the
assumed life-shortening effect related to palliative
sedation (Maltoni et al., 2009; Chiu et al., 2001;
Muller-Busch et al., 2003; Morita et al., 1999; Sykes
& Thorns, 2003; Maltoni et al., 2012).
Sometimes perceived as a more acceptable prac-
tice than euthanasia (Seymour et al., 2007; Georges
et al., 2008; Sercu et al., 2012) or physician-assisted
suicide (Pomerantz et al., 2004; Raus et al., 2011),
palliative sedation is often considered in the context
of a patient’s request for hastening death (Seale,
2010; Muller-Busch et al., 2003; Pomerantz et al.,
2004; Rietjens et al., 2009; Chambaere et al., 2010;
Raus et al., 2012; Blondeau et al., 2009). Rietjens
and coworkers (2008) found that in 9% of cases con-
tinuous deep sedation was preceded by an unsuccess-
ful request for euthanasia. Similarly, Blanker et al.
(2012) reported that in 77% of cases euthanasia was
discussed with the patient prior to the decision to
employ continuous sedation. Some authors have
suggested that in complex situations where patients
ask for hastening of death, unskilled or emotionally
exhausted physicians could apply sedation as an
easy alternative to physician-assisted suicide or eu-
thanasia (Morita et al., 2002; Billings & Block,
1996; Quill & Byock, 2000). Similar results were re-
ported by Blanker and colleagues (2012), who showed
that patients’ requests for euthanasia coincided with
a higher prevalence of pressure experienced by gen-
eral practitioners to start continuous sedation, es-
pecially by those without previous experience of
euthanasia.
In a study by Anquinet and colleagues (2012), the
variability in the prevalence of continuous deep seda-
tion appeared to reflect complex legal, cultural,
social, and organizational factors more than differ-
ences in patients’ characteristics or clinical profiles.
Similarly, Rietjens et al. (2012) found that physici-
ans’ openness to discuss sedation with patients and
relatives varies depending on local laws and ethics.
The present study focused on comparing the use of
sedation in two different socio-jurisdictional environ-
ments: one where euthanasia and physician-assisted
suicide are criminal practices (Quebec) and the other
where physician-assisted suicide is tolerated and eu-
thanasia prohibited (Switzerland).
Objectives
The aim of our study was to determine whether
different attitudes toward palliative sedation could
be observed between physicians from two socio-juris-
dictional environments where pertinent laws and
regulations differed. More precisely, it intended to
compare the attitudes of French-speaking physicians
from Quebec to those of French-speaking physicians
from Switzerland.
METHODS
Study Design and Measurement Instrument
The target population consisted of physicians work-
ing in palliative care who had the ability to prescribe
sedation in both the Province of Quebec and the
French cantons of Switzerland. The data from Que-
bec were drawn from a study performed in 2002–
2005 by Blondeau et al. (2005). The Swiss data
were drawn from a replicated study performed in
2009–2011 by Beauverd et al. (2013) in the cantons
of Vaud, Gene`ve, Neuchaˆtel, Valais, and Jura. Re-
spondents in Quebec practiced in palliative care
homes, in hospitals with a palliative care unit or
with beds for palliative care patients in various
wards, or within in-home palliative care. In Switzer-
land, they practiced in palliative care units, on pallia-
tive care mobile teams, and in rehabilitation centers
with palliative care beds.
The studies of Blondeau et al. (2005) and Beau-
verd et al. (2013) employed the same two-by-two
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experimental design, which manipulated two inde-
pendent variables: length of prognosis and type of
suffering. Four clinical vignettes were employed to
measure the effect of these variables (see the Appen-
dix). These vignettes consisted of sample situations
presenting different combinations of variables. The
measured dependent variable was the attitude
toward the use of palliative sedation.
In order to control the independent variables, each
respondent was assigned only one vignette. A defi-
nition of sedation was purposefully omitted in the
questionnaire to avoid bias. The attitudes toward
the use of palliative sedation were measured using
a 6-point Likert-type scale, ranging from 1 (strongly
disagree) to 6 (strongly agree). Respondents were
then asked an open question inviting them to com-
ment on their situation.
Data Analysis
Statistical analyses were performed with SAS 9.2
(Cary, North Carolina) software. A variance analysis
(unbalanced ANOVA) was performed by means of the
general linear models (GLM) procedure. This analy-
sis allowed measuring both the effect of the type of
suffering and prognosis length, and the effect of their
interaction on physicians’ attitudes toward sedation.
Attitudes toward sedation were then compared
between the two jurisdictions for each vignette. A
Wilcoxon test was then performed. This test was cho-
sen because of the limited size of the subsample of re-
spondents for each vignette.
The written comments were submitted to qualitat-
ive content analysis. Two members of the research
team separately analyzed the content of all written
comments and developed an open coding. Each unit
of analysis (word, phrase, or paragraph) was given
a code name and sorted into groups with related
themes. This process was continued until all of the
codes and categories were mutually exclusive and
covered all variations. A comparative process of
data analysis was then carried out. The two members
met together to compare and discuss their coding.
Each point of divergence was debated and clarified
until agreement on the set of codes was reached.
RESULTS
Respondents
The sample comprised 98 physicians from Quebec
and 77 from Switzerland. The Quebec sample was
48% female. About 47% were 45 years old, 41%
were 46–55 years old, and 11% were 56 years old.
About 31% had less than 6 years of experience in pal-
liative care; 31% had between 6 and 10 years of ex-
perience, and 38% had more than 10 years of
experience. The detailed results of the Quebec study
were reported by Blondeau et al. (2005). The Swiss
sample was 44% female. About 34% were 45 years
old, 31% were aged 46–55 years old, and 33% were
56 years old. About 29% had less than 6 years of ex-
perience in palliative care, 20% had between 6 and 10
years of experience, and 39% had more than 10 years
of experience. The detailed results of the Swiss study
were reported by Beauverd et al. (2013).
The analyses (chi-square test) indicated that the
four subgroups from Quebec and the four subgroups
from Switzerland (formed from the four clinical situ-
ations) were equivalent to each other in terms of sex
and experience in palliative care ( p . 0.05), but
different in terms of age ( p , 0.05). In Quebec, the
number of subjects per vignette ranged from 19 to
28, and in Switzerland from 15 to 25 (see Table 1).
Physicians’ Attitudes Toward Palliative
Sedation
The analysis of variance showed that only the type of
suffering variable had an effect on physicians’
attitudes toward sedation (Table 2). In fact, in both
jurisdictions neither prognosis nor sociodemographic
characteristics (sex, age, and years of experience in
palliative care) influenced physicians’ attitudes.
The results of the Wilcoxon test indicated that the
attitudes of physicians from Quebec and Switzerland
tended to be different for two vignettes: long-term
Table 1. Content of vignettes and respondents to each
Quebec Switzerland
Suffering Existential Physical Existential Physical
Prognosis
Long term Vignette 1 Vignette 2 Vignette 1 Vignette 2
n ¼ 21 (25%) n ¼ 15 (18%) n ¼ 17 (22%) n ¼ 20 (26%)
Short term Vignette 4 Vignette 3 Vignette 4 Vignette 3
n ¼ 23 (28%) n ¼ 24 (29%) n ¼ 15 (19%) n ¼ 25 (32%)
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prognosis with existential suffering ( p ¼ 0.0577) and
short-term prognosis with physical suffering ( p ¼
0.0914). In both cases, Swiss physicians were less
prone to employ palliative sedation (Table 3).
Written Comments
Written comments from Quebec respondents (n ¼
83/98) and Swiss respondents (n ¼ 77/77) were sum-
marized in a comparative perspective. The following
contents highlight their main personal concerns.
A number of participants, mainly from Quebec,
would agree that sedation is appropriate where the
patient’s prognosis is extremely guarded and phys-
ical suffering is intolerable and intractable. Some
Quebec participants would consider it inhumane to
allow someone to suffer without doing anything,
writing that “ethically, it’s the right thing to do”
(translated). Other Quebec and Swiss participants
would be more inclined to take recourse to sedation
only after all other pain relief alternatives were ex-
hausted. In the case of a long prognosis, however,
one Quebec participant wondered if sedation to
relieve physical suffering might become a kind of
“legal active euthanasia” (translated), while one
Swiss participant saw this as a proper situation for
assisted suicide.
In the absence of intractable physical symptoms
or uncontrolled pain, that is, only in the presence of
“existential” suffering, close to half of the Quebec
and Swiss participants did not see sedation as appro-
priate. Quebec participants noted that such suffering
is very common at the end of life. As one participant
put it, “If we prescribed terminal sedation for every
patient who brought up [wanting to die], we’d be put-
ting a lot of people to sleep” (translated). Other par-
ticipants from Quebec and Switzerland disapproved
of sedation for the relief of existential suffering where
the patient’s prognosis did not suggest impending
death. Some participants, particularly from Quebec,
saw the use of sedation in such conditions as unac-
ceptable, unethical, or as a form of abandonment of
the patient by the care team. Some participants,
mainly from Quebec, also saw sedation for the relief
of existential suffering as a form of euthanasia or as-
sisted suicide. “It still bothers me for a prognosis of
one or two months” (translated), wrote one Quebec
participant. “The patient looks on death as deliver-
ance, which for me blurs the line between sedation
and euthanasia” (translated). In such cases, Swiss
participants would be more inclined to discuss assis-
ted suicide with the patient. For them, it was inap-
propriate to propose sedation to patients who want
to die.
Some Quebec and Swiss participants were more
open to sedation in the case of existential suffering,
however. One Swiss participant expressed these
views by describing sedation as a “good alternative
to assisted suicide and something families might
be more likely to accept” (translated), while another
Swiss participant felt that “sedation is an acceptable
response because its first goal as a treatment is to
relieve an intractable symptom, not to affect life
Table 2. Physicians’ attitudes toward palliative sedation (mean+ standard deviation)
Quebec Switzerland
Suffering* Existential Physical Existential Physical
Prognosis†
Long term 2.65+1.57 5.06+1.35 1.88+1.54 4.75+1.71
Short term 3.00+1.77 5.29+1.01 2.62+2.06 4.54+1.67
Model F ¼ 21.95, df ¼ 3, p , 0.0001 F ¼ 12.34, df ¼ 3, p, 0.0001
*Suffering F ¼ 61.85, df ¼ 1, p, 0.0001 F ¼ 33.92, df ¼ 1, p, 0.0001
†Prognosis F ¼ 0.93, df ¼ 1, p ¼ 0.3361 F ¼ 0.41, df ¼ 1, p ¼ 0.5259
Suffering and prognosis F ¼ 0.04, df ¼ 1, p ¼ 0.8461 F ¼ 1.31, df ¼ 1, p ¼ 0.2567
Table 3. Comparison of the attitudes toward pallia-
tive sedation between the Quebec and Switzerland
subgroups
Vignette Quebec Switzerland Wilcoxon
Long-term
prognosis:
existential
suffering
2.65+1.57
n ¼ 26
1.88+1.54
n ¼ 17
0.0577
Long-term
prognosis:
physical pain
5.06+1.35
n ¼ 18
4.75+1.71
n ¼ 20
0.5730
Short-term
prognosis:
existential
suffering
3.00+1.77
n ¼ 26
2.62+2.06
n ¼ 13
0.3260
Short-term
prognosis:
physical pain 5.29+1.01
n ¼ 28
4.54+1.67
n ¼ 24
0.0914
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expectancy” (translated). There were also some Que-
bec participants who saw existential suffering as
equivalent to physical suffering and should therefore
be considered in the same way.
Both Quebec and Swiss participants felt it was im-
portant to discuss and clarify what the patient wan-
ted before considering sedation. As one Swiss
participant put it, “A loss of meaning doesn’t mean
you need to be put to sleep. And did the patient ask
for it?” (translated). Some participants, mainly from
Quebec, were more inclined toward sedation if it
was clear that this was what the patient wanted.
One Quebec participant wrote, “If the patient
‘clearly’ asks for it, I think not providing end-of-life
sedation would be unethical” (translated). A number
of participants, mainly from Quebec, were more fa-
vorable to sedation if the patient was able to consent
to it and had done so. As one Quebec participant put
it, “I think it’s okay to prescribe sedation but not to
impose it” (translated). Quebec and Swiss partici-
pants emphasized the importance of involving loved
ones in the process. Some participants, mainly from
Quebec, noted that consent from the patient’s family
should be obtained before sedation was initiated.
DISCUSSION
Our study results suggest that the attitudes of
the participating physicians from Quebec and
Switzerland toward palliative sedation, particularly
regarding prognosis and type of suffering, were simi-
lar, despite the different legislations in place regard-
ing physician-assisted suicide in their respective
environments of practice. The group from Quebec
did reach higher means on the Likert scale than did
the group from Switzerland for all vignettes, which
could suggest that respondents from Quebec would
be more open to palliative sedation than respondents
from Switzerland seemed to be, even though the ma-
jority were not in favor of sedation as an answer to
end-of-life existential suffering.
Faced with a request for a “hastened-death,” some
respondents from Switzerland would suggest consid-
ering physician-assisted suicide instead of palliative
sedation. This could mean that in Switzerland there
is a need to distinguish palliative sedation and
physician-assisted suicide. A study by Raus and col-
leagues (2011) demonstrated that physician-assisted
suicide and palliative sedation are usually applied
to different groups of patients. Physician-assisted
suicide is usually requested by terminal patients
who value control during the dying process and
who feel that their disease has harmed or threatens
to harm their dignity, while palliative sedation is em-
ployed predominantly for patients who want to avoid
pain and suffering (Raus et al., 2011). Different re-
sults were reported by Seale (2010), who found that
palliative sedation was associated with a higher
rate of requests from patients or relatives for a has-
tened death. In the same way, the physicians who
were in favor of assisted suicide legislation were
more likely to report using palliative sedation. As
this study was performed in the United Kingdom,
where physician-assisted suicide and euthanasia
are a criminal offence, this could suggest that pallia-
tive sedation is sometime used in response to re-
quests for a hastened death when physician-
assisted suicide or euthanasia is not an option.
Some respondents from Quebec would be in favor
of sedation for a patient experiencing severe psycho-
logical or existential suffering if the prognosis was
limited. These respondents mentioned that psycho-
logical or existential suffering should be given the
same consideration as physical pain. Intractable
psychological distress is sometimes the reason given
by physicians for starting palliative sedation (Seale,
2010), while others consider its use in such a situ-
ation as a death-hastening measure to be tanta-
mount to physician-assisted suicide or euthanasia
(Beel et al., 2002). In the current study, some respon-
dents from both Quebec and Switzerland would
equate using sedation in the presence of existential
suffering with a form of euthanasia, particularly if
the patient’s prognosis was longer.
Naturally, the desire for a hastened death depends
on numerous factors. This desire may fluctuate over
time (Goelitz, 2003) and may be influenced by inter-
ventions made by palliative care clinicians (Seale,
2010; Goelitz, 2003). As well, prior studies have re-
vealed concerns about patients requesting a has-
tened death in order to avoid being a burden to
others (Lee et al., 1996; Cavalieri et al., 2002) or
when they felt familial, institutional, or social press-
ures (Battin, 2008). In a study by Blanker et al.
(2012), general practitioners more often experienced
pressure from patients and their relatives to start
continuous sedation until death when patients had
a longer prognosis and showed psychological symp-
toms as compared to a shorter prognosis and physical
symptoms only.
It is often recommended that initiating palliative
sedation should be the result of a rigorous decision-
making process involving an interdisciplinary
team, the patient, and his loved ones (Moynier-Van-
tieghem & Beauverd, 2008; de Graeff & Dean,
2007; Goncalves et al., 2012). Few of our respondents
mentioned that the decision to use sedation should be
discussed with the care team. However, more respon-
dents considered that the utilization of sedation
should be discussed with patient and family. Some re-
spondents from both groups highlighted the impor-
tance of clarifying a patient’s desires, and would
Physicians’ attitudes toward palliative sedation 843
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agree to initiate sedation if this was congruent with
those desires. Similarly, obtaining the patient’s
agreement was also cited in both groups as a criterion
that should be met, which is in line with prior studies
(Claessens et al., 2008; Braun et al., 2003).
LIMITATIONS
Some of the limitations of our study include the years
separating the two studies (2004–2005 and 2009–
2011), the limited response rates in both (36% in
Switzerland and 42% in Quebec), and the study
population being restricted to physicians. Potential
confounding effects that could explain some differ-
ences observed between the two groups were not con-
trolled, such as physicians’ age and level of religious
faith. To facilitate interpretation of the results and
their analyses, the concepts of physical suffering
and existential suffering were separated in the vign-
ettes, which is rarely the case in daily clinical prac-
tice. Another limitation concerns the fact that only
two independent variables were investigated in our
study: length of prognosis and type of suffering.
Last, respondents were invited to comment about
their position only with respect to their specific vign-
ette, which may limit the generalizability of these
testimonies, despite their richness and relevance.
CONCLUSION
The attitudes of physicians from Quebec and
Switzerland toward palliative sedation, particularly
regarding prognosis and type of suffering, seem
similar, despite the different legislation in place
regarding physician-assisted suicide in each practice
environment. However, the results suggest that
physicians from Quebec could be slightly more open
to palliative sedation, even though the majority
were not in favor of this practice as an answer to
end-of-life existential suffering. In a context where
physician-assisted suicide is authorized, it is possible
that physicians are more inclined to favor physician-
assisted suicide over palliative sedation when pa-
tients experience existential suffering, particularly
if their prognosis is more extended.
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APPENDIX. CLINICALVIGNETTES
Clinical Vignette No. 1: Robert
Robert Casey has been married to Jane for 36 years. They
have two married sons and three granddaughters. He
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retired two years ago, two months before being diagnosed
with colorectal cancer (carcinoma). At that time, staging
did not indicate any spread of the tumor. He underwent a
left hemicolectomy with a colostomy. Resection margins
were clear, but 3 out of 10 ganglia were positive.
Some 15 months later, a recurrence was discovered in
the true pelvis. Examination showed a 3  5 cm mass
in the true pelvis, retroperitoneal ganglionic damage, and
two hepatic metastases (4 and 2.5 cm). Robert underwent
chemotherapy, which was terminated after six cycles be-
cause the illness was progressing.
Some 18 days ago, Robert was admitted to hospital in
the palliative care unit. His state of health is deteriorating
progressively. There is one major problem: the pain is not
subsiding despite multiple attempts to alleviate it. The
abdominal pain is diffuse, described as shooting with a sen-
sation of heaviness, and very sharp frequent exacerbations
in the form of stabbing pain that reaches an intensity of
10 out of 10 on the visual scale.
Examination shows that Robert has lost weight and is
jaundiced and very weak. His abdomen has increased in vo-
lume with moderate ascites. The hepatic lobe is painful to
palpation, and the liver is greater in volume and filled
with hard nodules. A recent investigation does not show
any lesion of the bone structure.
Multiple attempts to alleviate his pain have failed to
provide acceptable comfort for the patient. Robert is cur-
rently on the following medications:
† hydromorphone 5 mg/h continuous subcutaneous drip
and breakthrough doses every 30 minutes if needed
† gabapentin 400 mg, 1 capsule, 4 times daily
† dexamethasone 4 mg, subcutaneous, 4 times daily
† naproxen 500 mg, 1 tablet, twice daily
† ketamine 8 mg/h continuous subcutaneous drip
† amitryptiline 50 mg, 1 tablet at bedtime
† clonazepam 0.5 mg, 1 tablet lid, and 2 mg, 1 tablet at
bedtime
† haloperidol 1 mg, 1 tablet, twice daily
† laxatives (emollient and stimulant), bowel movements
are regular
Note. Methadone was tried but brought about major intol-
erable side effects; antiarrhythmics did not provide relief.
Given the patient’s state and considering how quickly he
is deteriorating, one can estimate a prognosis of no longer
than 5 to 10 days.
Robert is constantly in pain and rests only for short
periods of time. He has received 10 breakthrough doses
within the last 24 hours despite the fact that his medication
had been readjusted.
Clinical Vignette No. 2: Claire
Claire Germain is a 55-year-old lawyer and divorcee with
no children. However, her family network is large, and
she has many friends. Ovarian cancer (mucinous carci-
noma) was diagnosed 15 months ago. She underwent
surgeries: hysterectomy, oophorectomy, bilateral salpin-
gectomy, and cytoreduction of neoplastic implants found
at the peritoneal level. Last year, the cancer progressed
in spite of many cycles of different types of chemotherapy.
Claire has therefore been admitted to the palliative care
unit because the situation at home was becoming too try-
ing. She has multiple hepatic metastases and major perito-
neal carcinomatosis with no intestinal obstruction. She
also presents large ascites that were tapped twice in the
past 10 days. She suffers from diffuse pain in the abdomen
and the right lower part of the thorax. Analgesic medi-
cation makes her comfortable.
Examination shows that the patient has lost weight but
is not jaundiced. She is lucid but has slower motor skills.
She needs help with all her activities. Pulmonary ausculta-
tion shows a decreased vesicular murmur by one third on
the lower right, which is evidence of pleural effusion. The
patient is not, however, dyspneic. The abdomen has been
supple since the last ascites puncture; the multiple hepatic
and peritoneal nodules can be felt. Claire is on the following
medications:
† fentanyl 50 mg/h, 1 patch every 3 days
† hydromorphone 1 mg subcutaneously, every 30 min-
utes if in pain (she takes 1 breakthrough (dose every
2 days)
† naproxen 375 mg, 1 tablet twice daily
† lorazepam 1 mg, 1 tablet at bedtime
† laxatives (bowel movement every 2 to 3 days)
She is deteriorating quickly, and one can reasonably as-
sume that the prognosis is less than 10 days.
Physical pain is well alleviated and the patient feels
comfortable; however, she requires help with all her activi-
ties. She is grateful for the help given, but Claire says she
can no longer stand this deterioration, which she finds de-
grading. Despite the psychosocial support she receives
from the social worker and the joint follow-up by her phys-
ician, she constantly repeats that her life no longer “makes
sense.”
Clinical Vignette No. 3: Jim
Jim Foster is a retired civil engineer. Twice divorced, he has
been living with the same woman for the past 14 years. He
has two daughters (37 and 47 years old) from his first mar-
riage and one son (30 years old) from his second. He gets on
well with them, but they all live abroad. For the past 12
years, he has been suffering from prostate cancer.
Over the years, he has been treated in the usual manner
for this condition: prostatectomy, hormone therapy, chemo-
therapy, and radiotherapy. He has also taken part in clini-
cal trials during the past two years and has gone across the
border for a second opinion. However, the illness is out of
control. The last staging showed multiple osseous metasta-
ses, as well as major liver and ganglionic damage.
At his request, Jim has been hospitalized to lessen the
burden on the woman he lives with. Being younger than
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him, she works full time. Since his state of health has dete-
riorated, the patient needs a great deal of help with his
daily care and to just move around. He is fed up with being
dependent. His medications are as follows:
† morphine–LA 60 mg, 1 tablet twice daily
† morphine 10 mg, 1 tablet every hour if needed
† rofecoxib 25 mg, 1 tablet twice daily
† zoledronate 8 mg, IV every month
† biculatamide 50 mg, 1 tablet daily
† goselerine 10.8 mg, subcutaneously every 3 months
† omeprasole 20 mg, 1 tablet daily
† lorazepam mg, 1 tablet at bedtime
† acebutolol 200 mg, 1 tablet daily
† amlodipine 10 mg, 1 tablet daily
† isosorbide extended release 60 mg, 1 tablet daily
† acetylsalicylic acid 325 mg, 1 tablet daily
† lisinopril 20 mg, 1 tablet daily
This medication usually relieves his pain. From the way his
condition is changing, one can estimate his prognosis at one
to two months.
Jim constantly expresses his wish to die. Since his life
has no more meaning for him, he sees death as a release.
He mentions that his next of kin are aware of his wishes.
As for himself, he has nothing to expect from life in this
state of dependence on others. According to the psychiatrist
and the social worker, Jim shows no signs of depression and
is able to make decisions for himself.
Clinical Vignette No. 4: Julian
Julian Davis is a 60-year-old painter who has traveled the
world. He suffers from recurrent epidermoid carcinoma lo-
cated in the right oropharynx. Three years ago, he under-
went surgery and radiotherapy. Recurrence of the disease
was diagnosed six months ago. Because the tumor could
not be treated surgically, radiotherapy and chemotherapy
were indicated. The initial response was positive, but even-
tually the lesion continued developing. It has now spread to
the right side of the neck, but there is no skin ulceration.
The patient complains of shooting pain, a burning feel-
ing, and neuralgia on the right side of the cervix, with
pain spreading toward the right ear. This pain is rated at
9–10/10 and drops to 8/10 for short periods following
breakthrough doses. Medications are as follows:
† fentanyl 250 mg/h patches
† morphine 20 mg, subcutaneously every 30 minutes if
any discomfort
† methotrimeprazine 15 mg, subcutaneously 4 times
daily
† sodium naproxen 500 mg, twice daily
† dexamethasone 4 mg, subcutaneously 4 times daily
† clonazepam 1 mg, 4 times daily
† gabapentin 800 mg, 1 capsule 4 times daily
† flecainide 100 mg, 1.5 tablets twice daily
† omeprasole 20 mg, 1 tablet daily
† laxatives
† olanzapine 7.5 mg regularly at bedtime and 5 mg 3
times daily if confused or agitated
The pain has not subsided, despite multiple attempts to al-
leviate symptoms, and Julian experiences constant discom-
fort. The pain is never under the 8/10 level, which he finds
unbearable. Any increase in analgesic medication is ham-
pered because of major side effects, such as cognitive im-
pairment and agitation. Methadone, ketamine, clonidine,
and topiramate have been tried without results or, worse,
with unbearable side effects.
The patient was admitted to the palliative care unit
many weeks ago. He is progressively deteriorating, losing
weight, and becoming increasingly tired. The professionals
who care for him think his prognosis is between four and
eight weeks.
Julian repeats over and over again that he cannot bear
the situation any longer. He is obsessed with the discomfort
and pain, which have taken over his whole life. He asks you
to do something.
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